Health care trajectories and medication consumption of substance users in treatment : linking TDI and IMA databases (Belgium) De Ridder Karin, Antoine.

Slides:



Advertisements
Similar presentations
M. Fe Caces, Ph.D. Statistician/Demographer Office of National Drug Control Policy Executive Office of the President Washington, DC Presentation for the.
Advertisements

Etienne Maffli Swiss Institute for the Prevention of Alcohol and other Drug Problems Lausanne, Switzerland Characteristics of male and female outpatients.
Delay from Testing HIV Positive until First HIV Care for Drug Users: Adverse Consequences and Possible Solutions Barbara J Turner MD, MSEd* John Fleishman.
Correlates of polydrug use among injection drug users: The role of socioeconomic stress and quality of life Marrero CA, Robles RR, Reyes JC, Matos TD,
HIV Risk Behaviors and Alcohol Intoxication among Injection Drug Users in Puerto Rico Tomás D. Matos, MS Center for Addiction Studies Universidad Central.
SOUTH CAROLINA EPIDEMIOLOGIC PROFILE Data available in an Integrated Epidemiologic Profile Core Epi Section Socio-demographic characteristics of.
Project Update : Claims/Clinical Linkage Project MHDO Board of Directors June 6, 2013.
RESEARCHERS‘ ACCESS TO HEALTH DATA – FACTS AND CHALLENGES Metka Zaletel National Institute of Public Health 24 March 2015.
DR. MICHIEL CALLENS INTERMUTUALISTIC AGENCY (IMA-AIM) What can reimbursement data tell us about binge drinking in Belgian minors?
1 Lauren E. Finn, 2 Seth Sheffler-Collins, MPH, 2 Marcelo Fernandez-Viña, MPH, 2 Claire Newbern, PhD, 1 Dr. Alison Evans, ScD., 1 Drexel University School.
Controlled Substance Prescribing Trends and Physician and Pharmacy Utilization Patterns: Epidemiological Analysis of the Maine Prescription Monitoring.
The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.
National Research and Development Centre for Welfare and Health Knowledge for welfare and health1 Finnish Drug Treatment Information System Kristiina Kuussaari,
The Role of the CPCDMS in QM Activities Elizabeth Love, MPH Harris County Public Health and Environmental Services Department HIV Services Section.
NUMBER OF MENTALLY DISORDERED PERSONS ( POPULATION) Data of State Mental Health Centre of Lithuania.
Treatment system-based data collection: an integrated approach to monitoring Expert meeting: Implementation of the treatment strategy EMCDDA Lisbon,
SLIDE 1 of 34 IS THERE A CAUSAL RELATIONSHIP BETWEEN SUBSTANCE ABUSE AND PSYCHIATRIC ILLNESS? Dr Martin Frisher Department of Medicines Management Keele.
The Prescription Behavior Surveillance System: Applications of De-identified PDMP Data in Public Health Surveillance Rx Abuse Summit April 23, 2014 Peter.
Prevalence of Chronic Disease & Comorbid Conditions in the CHAIN Cohort CHAIN Report Peter Messeri, Gunjeong Lee, Sara Berk Mailman School of Public.
APPLICATION OF THE START-STOPP CRITERIA ON AN ELDERLY POPULATION IN BELGIAN GENERAL PRACTICE: an explorative study J. Landa 1, A. Torsin 1, T. Cornelissen.
Obtaining housing associated with achieving abstinence after detoxification in adults with addiction Tae Woo Park, Christine Maynié-François, Richard Saitz.
July 31, 2009Prepared by the Maine Health Information Center Overview of All Payer Claims Data Suanne Singer, Senior Consultant Maine Health Information.
Blattler et al (2002). Aim To investigate whether supplying heroin on a medical programme, combined with therapy, would reduce cocaine use among participants,
Analyzing NCHS Drug Data Amy B. Bernstein, Sc.D. Presented at the NCHS Board of Scientific Counselors Meeting January 28, 2005 U.S. DEPARTMENT OF HEALTH.
Strategic Plans. Analysis in Joint Commissioning Cycle >Analysis key part of commissioning cycle. >Analysis sets out thinking, reasoning, decisions for.
Activity in out-of-hours services in Norway, th Nordic Congress of General Practice May 2009, Copenhagen Elisabeth Holm Hansen, Erik Zakariassen,
MINISTRY OF SOCIAL AFFAIRS AND HEALTH 1 The Finnish National Electronic Patient Record Archive
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
Developing Quality Indicators & Dashboards for Dementia Adam Cook South East Coast Quality Observatory.
Evaluating Mental Health System Enhancements Investigators: Heather Stuart, PhD and Terry Krupa, PhD, Queen’s University Research Associate: Michelle Koller,
The “Sastipen Network Information System” Facing Drugs within the Roma Community: Gathering of Information for the development of indicators “The Sastipen.
Study Finds Persons Who Fill Buprenorphine Prescriptions Have Higher Rates of Medical Conditions Associated with Pain and Comorbid Psychiatric Disorders.
Linda Montanari, Buenos Aires, October 2003 CICAD/OAS, Demand Reduction Experts Group Meeting The Information System on Treatment Demand in EU EMCDDA.
Introduction Introduction Alcohol Abuse Characteristics Results and Conclusions Results and Conclusions Analyses comparing primary substance of abuse indicated.
Promoting Excellence in Family Medicine RCGP Weekly Returns Service data extraction D. M. Fleming Director, Research and Surveillance Centre Nottingham.
International E-Health Conference “E-Health:around the clock care for everyone, everywhere” Quality in Health Care and Medical care E-Health in Friuli.
Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.
Senior Drug Users: Scotland April Shaw & Austin Smith November 2009.
Introduction Results and Conclusions On counselor background variables, no differences were found between the MH and SA COSPD specialists on race/ethnicity,
Substance Use among Older Adults (Age 50+): Current Prevalence and Future Expectations Presented by Joe Gfroerer U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES.
Using the new treatment prevalence protocol in Ireland Suzi Lyons.
Older People’s Services The Single Assessment Process.
© National Confidential Inquiry into Suicide and Homicide by People with Mental Illness. All rights reserved. Not to be reproduced in whole or in part.
UCLA Integrated Substance Abuse Programs Richard Rawson, Ph.D. Rachel Gonzales, Ph.D. Funded by: California Alcohol and Drug Programs CalOMS Training for.
DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration OFFICE OF APPLIED STUDIES Treatment Episode Data Set.
Printed by A Follow-Up Study of Patterns of Service Use and Cost of Care for Discharged State Hospital Clients in Community-Based.
Lecture 5 Morbidity of population as medical- social problem. Epidemiological methods for studying morbidity.
Data quality and feedback from the assessment on 2000 and 2001 TDI data 1 EMCDDA, TDI meeting, 23/24 June 2003 Luis Royuela.
Introduction Results and Conclusions Numerous demographic variables were found to be associated with treatment completion. Completers were more likely.
1 READY BY 21 TASKFORCE Harford County Department of Community Services Local Management Board Health Benchmark December 7, 2010.
Pediatric Asthma Hospitalizations: Impact of Managed Care in the Patterns of Outpatient Healthcare Utilization Capriles, JA., Rodríguez, MH., Rios, R.,
Medical Drugs, Intoxication Substances, and Somatic Diseases Evgeniya Koshkina Deputy Director for Science Moscow Research and Practical Centre on Addictions.
Collaboration between the national EWS and treatment service providers in Hungary Anna Péterfi Hungarian National Focal Point TAIEX seminar Zagreb,
A ssociation of Public Health Observatories Hospital Activity data Roy Maxwell SWPHO & Bristol University Dr Richard Wilson Sandwell PCT.
Introduction Data Statistical Methods Table 1: Prevalence of Prior Hip Fracture and Incidence of New Hip Fractures and Fractures of Any Type.
Health & Social Care Information Centre SEPHIG: 12 th September, 2012.
Introduction to Hospital Episode Statistics (HES) Robel Feleke Knowledge and Intelligence Team (London) 20 th February 2014.
PSY 425 Week 2 Individual Drug Profile Paper To purchase this material click on below link
Current Mental Health Care Systems
Current Mental Health Care Systems
Assessment of Injection Drug Use Based on Diagnostic Codes in Administrative Datasets M Kuo 1, NZ Janjua 1,2, AYW Yu 1, N Islam 1,2, H Samji 1, JA Buxton.
Current Mental Health Care Systems
Public expenditure on drug treatment and associated comorbidities: a case study of Bergamo Sabrina Molinaro, PhD Institute of Clinical Physiology ,National.
Linda Montanari Programme P1: Monitoring the Situation
2018 Delaware State Epidemiological Profile
Registration of treatment demands for substance use disorders in Belgium : Why are some clients registered anonymously? Jérôme Antoine, Françoise Renard.
outpatient drug or alcohol clinic, mental health or community health center, private mental health professional, in-home counseling or crisis services,
German Drug and Addiction Policy
Surveillance of Tuberculosis
Megan Eguchi, MPh Sana karam, md, phd
Presentation transcript:

Health care trajectories and medication consumption of substance users in treatment : linking TDI and IMA databases (Belgium) De Ridder Karin, Antoine Jérôme, Gremeaux Lies, Plettinckx Els, Blanckaert Peter, Tafforeau Jean. WIV-ISP | Rue Juliette Wytsmanstraat 14 | 1050 Brussels | Belgium T | | site web: Background Problem substance use has a relative low prevalence and is often socially stigmatised: health care trajectories and medication consumption among substance users are notoriously difficult to study The Belgian Treatment Demand Indicator register (TDI): An European standardized tool collecting information on substance users getting in contact with health professionals (tdi.wiv-isp.be) Linkage with the health care and prescription register of the Belgian national compulsory health insurance (IMA)( to create a data source in which longitudinal and case-control research on medication consumption and health care trajectories among substance users in treatment can be performedwww.ima-aim.be Methods TDI register: Registration of every new treatment episode started in a treatment centre for alcohol or illicit drug abuse Limitation: only new treatment episodes for substance use are registered and as such, it should be considered as an incidence register. On its own, it can’t serve as source for longitudinal studies on the individual level nor case-control studies. Extraction of records from centres specialized in treatment of drug addiction, some centres of mental health and general or psychiatric hospitals from 2011 until 2014 Data on the client's socio-demographic profile, substance use pattern and treatment information IMA databases Data from seven Belgian Health Insurance Organizations in three national databases: (1) population database with socio-demographic data, (2) health care database with administrative information on reimbursed health care provision (3) Farmanet database with data on reimbursed prescriptions Limitation: difficult to identify patients with substance use problem Extraction of selected data related to socio-demography, health care and prescriptions from 2008 until TDI IMA 2017 Time periods of data used in linkage: Results 69% (N=34,628) of the TDI records have a unique NIN and are eligible for linkage with the three IMA databases (table 1) Among them, 75% were male (figure 1), mean age was 36.5 years and 94% were Belgian citizens Besides the 41% in treatment for primary substance “alcohol”, 21% of the clients reported to be in treatment for cannabis, followed by opiates (17%), cocaine (9%) and stimulants other than cocaine (7%) (figure 2) In 46% of the cases, the clients were registered in an outpatient treatment program, while 54% were in inpatient health care Identification type Year of treatment start Total National identification number (NIN) 5,510 (77%) 7,657 (75%) 10,059 (70%) 11,402 (61%) 34,628 (69%) Other non unique identification type 1,6682,5754,3327,08815,663 (31%) Total7,17810,2321,439118,49050,291 (100%) Table 1 : Number of patients (first treatment episode registered by patient) in the TDI database (Year of treatment start and identification type are indicated) Figure 1 : Proportion of TDI patients eligible for linkage by age categories and sex Figure 2: Proportion of TDI patients eligible for linkage by primary substance used Conclusions A linkage of TDI and IMA databases will result in the first large-scaled longitudinal database in the Belgian drug epidemiology Covers a 10-years period and enables a comparison with a matched control group Individual and treatment centres characteristics can be taken into account First crucial practical steps: Recoding the project ID code used in TDI back to the NIN Evaluate the linkage rate between TDI and IMA registers Linkage Both registers will be linked by a coded version of the patient’s unique national identification number (NIN). In the TDI register, the use of this NIN is not mandatory, so a selection of records has to be made A Trusted Third Party (eHealth) is to decode, link and recode the NIN in order to link both registers Case-control matching (1:4) Aim: comparison of medical consumption of persons in drug treatment with persons who did not enter into drug treatment Each TDI case will be matched by sex, age and municipality with four control persons from the IMA population database who have no administrative registrations of treatment for substance addiction in the IMA registers and TDI register Privacy commission Approved by the Privacy Commission (SCSZG/15/033) Progression The linkage will be executed from autumn 2015 with a yearly update with IMA data, up to and including the administrative registration year 2017